FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. Test only reports 3 out of more than 1,000 known BRCA mutations and negative result doesn’t rule out increased cancer risk

The U.S. Food and Drug Administration today authorized the Personal Genome Service Genetic Health Risk…

Get A Free Gift

Your Mammogram: The Questions to Ask Before, During, and After Your Exam